35.64 MUSD
316.61 MUSD
11.43 M
About Eagle Pharmaceuticals, Inc.
Sector
CEO
Michael Graves
Headquarters
Woodcliff Lake
Website
Employees (FY)
135
Founded
2007
ISIN
US2697961082
FIGI
BBG005Y3XWH9
Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of EGRX is 4.62 USD — it has increased by 5.24% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Eagle Pharmaceuticals, Inc. stocks are traded under the ticker EGRX.
Eagle Pharmaceuticals, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
EGRX stock is 5.96% volatile and has beta coefficient of −0.32. Check out the list of the most volatile stocks — is Eagle Pharmaceuticals, Inc. there?
EGRX earnings for the last quarter are 1.26 USD whereas the estimation was 1.05 USD which accounts for 20.00% surprise. Estimated earnings for the next quarter are 1.05 USD. See more details about Eagle Pharmaceuticals, Inc. earnings.
Eagle Pharmaceuticals, Inc. revenue for the last quarter amounts to 66.31 M USD despite the estimated figure of 63.22 M USD. In the next quarter revenue is expected to reach 59.11 M USD.
Yes, you can track Eagle Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
EGRX stock has fallen by 1.70% compared to the previous week, the month change is a 17.35% fall, over the last year Eagle Pharmaceuticals, Inc. has showed a 83.42% decrease.
Today Eagle Pharmaceuticals, Inc. has the market capitalization of 57.01 M, it has increased by 11.11% over the last week.
No, EGRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EGRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Eagle Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 135.00 employees. See our rating of the largest employees — is Eagle Pharmaceuticals, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Eagle Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Eagle Pharmaceuticals, Inc. stock shows the sell signal. See more of Eagle Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.